Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome
Conclusion: Sertraline and other SSRI medications can cause MBA in patients with PWS at typical starting doses, although risk for adverse effects increases with higher doses. Age is a contributing factor. Knowing the genetic subtype of PWS is essential for making clinical decisions about pharmacothe...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/crps/9811985 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849722628406771712 |
|---|---|
| author | Janice Forster |
| author_facet | Janice Forster |
| author_sort | Janice Forster |
| collection | DOAJ |
| description | Conclusion: Sertraline and other SSRI medications can cause MBA in patients with PWS at typical starting doses, although risk for adverse effects increases with higher doses. Age is a contributing factor. Knowing the genetic subtype of PWS is essential for making clinical decisions about pharmacotherapy, and results of pharmacogenomic testing may inform the selection of medication, dose, and schedule of administration. |
| format | Article |
| id | doaj-art-6b455aa4811642c69d5a735912554f9e |
| institution | DOAJ |
| issn | 2090-6838 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Psychiatry |
| spelling | doaj-art-6b455aa4811642c69d5a735912554f9e2025-08-20T03:11:17ZengWileyCase Reports in Psychiatry2090-68382025-01-01202510.1155/crps/9811985Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi SyndromeJanice Forster0Pittsburgh PartnershipConclusion: Sertraline and other SSRI medications can cause MBA in patients with PWS at typical starting doses, although risk for adverse effects increases with higher doses. Age is a contributing factor. Knowing the genetic subtype of PWS is essential for making clinical decisions about pharmacotherapy, and results of pharmacogenomic testing may inform the selection of medication, dose, and schedule of administration.http://dx.doi.org/10.1155/crps/9811985 |
| spellingShingle | Janice Forster Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome Case Reports in Psychiatry |
| title | Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome |
| title_full | Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome |
| title_fullStr | Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome |
| title_full_unstemmed | Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome |
| title_short | Sertraline-Induced Mood and Behavioral Activation in Two Adults With Prader–Willi Syndrome |
| title_sort | sertraline induced mood and behavioral activation in two adults with prader willi syndrome |
| url | http://dx.doi.org/10.1155/crps/9811985 |
| work_keys_str_mv | AT janiceforster sertralineinducedmoodandbehavioralactivationintwoadultswithpraderwillisyndrome |